A Randomized Phase II Trial of Pre-Operative Chemoradiotherapy With or Without Cetuximab (ERBITUX) in Locally-Advanced Adenocarcinoma of the Rectum.
Phase of Trial: Phase II
Latest Information Update: 05 Nov 2016
At a glance
- Drugs Cetuximab (Primary) ; Fluorouracil
- Indications Rectal cancer
- Focus Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 07 Nov 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 18 Jan 2014 Primary endpoint 'Pathological-response-rate' has not been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History